The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies allotted bonus shares on December 1, 2025 in a 2:1 ratio (two bonus shares for every one held). Promoter group entity Docon Technologies Pvt Ltd has disclosed that a fresh pledge has been created on 6,46,46,464 bonus shares in favour of Catalyst Trusteeship Limited (acting as debenture trustee for API Holdings Limited). This takes Docon's total encumbered shares from 3,23,23,232 to 9,69,69,696. The percentage of shares pledged remains unchanged at 60.93% of Thyrocare's total share capital, because the bonus issue increased both encumbered and unencumbered holdings proportionally. There is no change in promoter shareholding or in the proportion of pledged shares.
For shareholders, this is a routine disclosure triggered mechanically by the bonus issue — no new debt or risk has been added beyond what already existed. However, the fact that over 60% of promoter-held shares remain pledged to secure API Holdings' debentures is a material overhang and worth monitoring.